Ph.D. WEI-WU HE - 17 Nov 2021 Form 4 Insider Report for CASI Pharmaceuticals, Inc.

Signature
/s/ Amanda Cui, attorney-in-fact for Wei-Wu He
Issuer symbol
N/A
Transactions as of
17 Nov 2021
Net transactions value
+$394,000
Form type
4
Filing time
19 Nov 2021, 15:10:08 UTC
Previous filing
20 Aug 2021
Next filing
17 Jun 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CASI Common Stock Purchase $198,000 +200,000 +3.9% $0.9900* 5,362,569 17 Nov 2021 Direct F1
transaction CASI Common Stock Purchase $196,000 +200,000 +3.7% $0.9800* 5,558,472 18 Nov 2021 Direct F1
holding CASI Common Stock 3,000,000 17 Nov 2021 See Footnote F2
holding CASI Common Stock 7,532,347 17 Nov 2021 See Footnote F3
holding CASI Common Stock 441,072 17 Nov 2021 See Footnote F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reported price is a weighted average purchase price. These shares were purchased in multiple transactions at prices ranging from $0.98 to $1.00 per share on November 17, 2021 and $0.96 to $1.00 per shares on November 18, 2021. The Reporting Person undertakes to provide to the issuer, or any shareholder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
F2 The shares are held indirectly in the name of ETP BioHealth III Fund, LP, a limited partnership of which the Reporting Person is the managing member of the general partner. The Reporting Person disclaims beneficial ownership over any shares held indirectly, except to the extent of his pecuniary interest therein and his filing is not an admission that the Reporting Person is the beneficial owner of these shares for purposes of Section 16 or any other purposes.
F3 The shares are held indirectly in the name of ETP Global Fund LP, a limited partnership of which the Reporting Person is the managing member of the general partner. The Reporting Person disclaims beneficial ownership over any shares held indirectly, except to the extent of his pecuniary interest therein and his filing is not an admission that the Reporting Person is the beneficial owner of these shares for purposes of Section 16 or any other purposes.
F4 The shares are held indirectly in the name of Emerging Technology Partners, LLC, an LLC entity of which the Reporting Person is the managing member. The Reporting Person disclaims beneficial ownership over any shares held indirectly, except to the extent of his pecuniary interest thein and his filing is not an admission that the Reporting Person is the beneficial owner of these shares for the purposes of Section 16 or any other purposes.

Remarks:

Power of Attorney